We are live on
!
Find out more
Parallel Advisors Portfolio holdings
AUM
$6.56B
Turnover
11.49%
1-Year Est. Return
32.24%
This Fund
S&P 500
This Quarter
Est. Return
-14.06%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$1.24B
AUM Growth
-$98.1M
(-7.4%)
Cap. Flow
+$139M
Cap. Flow
% of AUM
11.27%
Top 10 Holdings %
Top 10 Hldgs %
39.9%
Holding
2,819
New
365
Increased
978
Reduced
847
Closed
217
Avg Time Held Equity + Options
2.1
years
Top 10 Avg Time Held Equity + Options
1.3
years
Top 20 Avg Time Held Equity + Options
1.5
years
Avg Time Held Equity only
2.1
years
Top 10 Avg Time Held Equity only
1.3
years
Top 20 Avg Time Held Equity only
1.5
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVB Financial
CVBF
|
+$78.5M |
| 2 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$48.7M |
| 3 |
iShares MSCI USA Quality Factor ETF
QUAL
|
+$16.1M |
| 4 |
PIMCO Active Bond Exchange-Traded Fund
BOND
|
+$10.8M |
| 5 |
iShares US Treasury Bond ETF
GOVT
|
+$8.25M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI USA Momentum Factor ETF
MTUM
|
+$13.1M |
| 2 |
iShares Core S&P Small-Cap ETF
IJR
|
+$7.79M |
| 3 |
iShares Core MSCI EAFE ETF
IEFA
|
+$6.79M |
| 4 |
State Street SPDR Portfolio S&P 1500 Composite Stock Market ETF
SPTM
|
+$6.62M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$6.23M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 54.43% |
| 2 | Technology | 12.95% |
| 3 | Financials | 11.18% |
| 4 | Healthcare | 5.67% |
| 5 | Consumer Discretionary | 3.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
326
Amdocs
DOX
$6.34B
| $350K | 0.03% |
6,373
-3,534
| -36% | -$237K |
2016 Q4
13 quarters
|
|
327
Estee Lauder
EL
$38.8B
| $350K | 0.03% |
2,201
+223
| +11% | +$43K |
2016 Q4
13 quarters
|
|
328
Advanced Micro Devices
AMD
$918B
| $338K | 0.03% |
7,446
+1,604
| +27% | +$77.3K |
2016 Q4
13 quarters
|
|
329
Insulet
PODD
$9.62B
| $333K | 0.03% |
2,015
-25
| -1% | -$4.57K |
2018 Q3
6 quarters
|
|
330
Invesco S&P 500 Equal Weight Health Care ETF
RSPH
$937M
| $330K | 0.03% |
17,490
| – | – |
2017 Q1
12 quarters
|
|
331
Sanofi
SNY
$96.5B
| $330K | 0.03% |
7,557
+1,472
| +24% | +$70.4K |
2016 Q4
13 quarters
|
|
332
Marsh
MRSH
$89B
| $329K | 0.03% |
3,813
-903
| -19% | -$96.3K |
2016 Q4
13 quarters
|
|
333
Chunghwa Telecom
CHT
$37B
| $326K | 0.03% |
9,176
-1,095
| -11% | -$39.5K |
2016 Q4
13 quarters
|
|
334
iShares 1-3 Year Treasury Bond ETF
SHY
$26.8B
| $326K | 0.03% |
3,765
-1,044
| -22% | -$89.2K |
2016 Q4
13 quarters
|
|
335
Xcel Energy
XEL
$46.9B
| $324K | 0.03% |
5,373
+326
| +6% | +$21.2K |
2016 Q4
13 quarters
|
|
336
iShares Russell Mid-Cap ETF
IWR
$56.6B
| $321K | 0.03% |
7,436
+2,613
| +54% | +$144K |
2016 Q4
13 quarters
|
|
337
Progressive
PGR
$124B
| $320K | 0.03% |
4,334
+2,102
| +94% | +$162K |
2016 Q4
13 quarters
|
|
338
Prologis
PLD
$121B
| $320K | 0.03% |
3,989
-385
| -9% | -$33.6K |
2016 Q4
13 quarters
|
|
339
WEC Energy
WEC
$34.6B
| $318K | 0.03% |
3,611
+381
| +12% | +$36.6K |
2016 Q4
13 quarters
|
|
340
iShares Russell Mid-Cap Growth ETF
IWP
$19.3B
| $317K | 0.03% |
5,218
| – | – |
2016 Q4
13 quarters
|
|
341
McCormick & Company Non-Voting
MKC
$12.3B
| $316K | 0.03% |
4,488
+216
| +5% | +$16.8K |
2016 Q4
13 quarters
|
|
342
Veeva Systems
VEEV
$50.7B
| $316K | 0.03% |
2,027
+181
| +10% | +$26.5K |
2018 Q3
6 quarters
|
|
343
Quest Diagnostics
DGX
$26.4B
| $312K | 0.03% |
3,894
+2,873
| +281% | +$297K |
2016 Q4
13 quarters
|
|
344
iShares ESG Optimized MSCI USA ETF
SUSA
$4.1B
| $306K | 0.02% |
5,582
| – | – |
2016 Q4
13 quarters
|
|
345
Toyota
TM
$226B
| $306K | 0.02% |
2,554
+1,069
| +72% | +$143K |
2016 Q4
13 quarters
|
|
346
State Street Financial Select Sector SPDR ETF
XLF
$51.4B
| $306K | 0.02% |
14,712
-8,906
| -38% | -$245K |
2016 Q4
13 quarters
|
|
347
Guardant Health
GH
$22.3B
| $305K | 0.02% |
4,386
+4,355
| +14,048% | +$334K |
2019 Q1
4 quarters
|
|
348
VanEck Semiconductor ETF
SMH
$68.1B
| $304K | 0.02% |
+5,200
| New | +$351K |
2020 Q1
0 quarters
|
|
349
Vertex Pharmaceuticals
VRTX
$129B
| $303K | 0.02% |
1,276
+149
| +13% | +$34.2K |
2016 Q4
13 quarters
|
|
350
iShares 7-10 Year Treasury Bond ETF
IEF
$41.7B
| $299K | 0.02% |
2,463
+57
| +2% | +$6.56K |
2016 Q4
13 quarters
|
|
Similar funds
Parallel Advisors's Q1 2020 Portfolio in Review
As of Q1 2020, Parallel Advisors held 2,819 positions worth $1.24B, down 7.4% from $1.33B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Parallel Advisors deployed $139M of net new capital in Q1 2020, opening 365 new positions and adding to 978 existing holdings. Its largest new stake was Adverum Biotechnologies: 5,766 shares worth $563K.
By sector, the portfolio is most concentrated in Miscellaneous at 54% of assets, down from 59% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was iShares MSCI USA Momentum Factor ETF, an estimated $13.1M trimmed.
- Parallel Advisors's largest Q1 2020 buy was Adverum Biotechnologies: 5,766 shares worth $563K.
- Parallel Advisors added most to CVB Financial in Q1 2020, an estimated $78.5M increase.
- Parallel Advisors's biggest Q1 2020 reduction was iShares MSCI USA Momentum Factor ETF, cutting an estimated $13.1M.
- Parallel Advisors fully exited State Street SPDR Portfolio Mortgage Backed Bond ETF in Q1 2020, selling an estimated $1.38M.
- Parallel Advisors's ten largest holdings make up 40% of its $1.24B portfolio in Q1 2020.
- Parallel Advisors opened 365 new positions and closed 217 in Q1 2020.
- Parallel Advisors's portfolio value fell 7.4% quarter-over-quarter to $1.24B.
Based on Parallel Advisors's 13F filing for Q1 2020, filed 27 Apr 2020.